Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?

Ther Drug Monit. 2020 Apr;42(2):347-348. doi: 10.1097/FTD.0000000000000728.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / pharmacokinetics*
  • Area Under Curve
  • Cytochrome P-450 CYP3A / genetics
  • Dose-Response Relationship, Drug
  • Drug Monitoring / methods*
  • Female
  • Humans
  • Linezolid / blood
  • Linezolid / pharmacokinetics*
  • Pharmacogenetics

Substances

  • Anti-Bacterial Agents
  • Cytochrome P-450 CYP3A
  • Linezolid